Skip to main content
Veterinary Medicines

SYVAC ERY emulsion for injection for pigs

Authorised
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated

Product identification

Medicine name:
SYVAC ERY EMULSION INYECTABLE PARA PORCINO
SYVAC ERY emulsion for injection for pigs
Active substance:
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated
    61.00
    enzyme-linked immunosorbent assay unit
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB03
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:
  • cardboard box containing 1 vial containing 100 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Syva S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Syva S.A.U.
Responsible authority:
  • The Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 4002 ESP
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0396/001
Concerned member states:
  • Portugal

Documents

Summary of Product Characteristics

English (PDF)
Published on: 12/04/2023
Download
Spanish (PDF)
Published on: 17/03/2023

Package Leaflet

English (PDF)
Published on: 12/04/2023
Download
Spanish (PDF)
Published on: 17/03/2023

Labelling

English (PDF)
Published on: 12/04/2023
Download
Spanish (PDF)
Published on: 17/03/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."